Cysteine misincorporation in bacterially expressed human α-synuclein

FEBS Letters

Volumn 580, Issue 7, 2006, Pages 1775-1779

  Masuda, Masami ^a,b   Dohmae, Naoshi ^c   Nonaka, Takashi ^a   Oikawa, Takayuki ^a,b   Hisanaga, Shin Ichi ^b   Goedert, Michel ^d   Hasegawa, Masato ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO METROPOLITAN UNIVERSITY   (Japan)

^c RIKEN   (Japan)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Synuclein; Aggregation; Cysteine; Dimerization; Mistranslation

Indexed keywords

ALPHA SYNUCLEIN; CYSTEINE; RECOMBINANT PROTEIN;

ARTICLE; CODON; DIMERIZATION; ESCHERICHIA COLI; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CLONING, MOLECULAR; CYSTEINE; DIMERIZATION; ESCHERICHIA COLI; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROTEIN BIOSYNTHESIS;

ESCHERICHIA COLI;

EID: 33644911177     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.02.032     Document Type: Article

References (17)

1. M. Goedert Alpha-synuclein and neurodegenerative diseases Nat. Rev. Neurosci. 2 2001 492 501
2. H. Fujiwara, M. Hasegawa, N. Dohmae, A. Kawashima, E. Masliah, M.S. Goldberg, J. Shen, K. Takio, and T. Iwatsubo α-Synuclein is phosphorylated in synucleinopathy lesions Nat. Cell Biol. 4 2002 160 164
3. M. Hasegawa, H. Fujiwara, T. Nonaka, K. Wakabayashi, H. Takahashi, V.M.-Y. Lee, J.Q. Trojanowski, D. Mann, and T. Iwatsubo Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions J. Biol. Chem. 277 2002 49071 49076
4. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, and R.L. Nussbaum Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
5. R. Krüger, W. Kuhn, T. Müller, D. Woitalla, M. Graeber, S. Kösel, H. Przuntek, J.T. Epplen, L. Schöls, and O. Riess Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease Nat. Genet. 18 1998 106 108
6. J.J. Zarranz, J. Alegre, J.C. Gómez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atarés, V. Llorens, E. Gomez-Tortosa, T. del Ser, D.G. Munoz, and J.G. de Yebenes The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2004 164 173
7. J.L. Eriksen, S. Przedborski, and L. Petrucelli Gene dosage and pathogenesis of Parkinson's disease Trends Mol. Med. 3 2005 91 96
8. L.C. Serpell, J. Berriman, R. Jakes, M. Goedert, and R.A. Crowther Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation Proc. Natl. Acad. Sci. USA 97 2000 4897 4902
9. W. Choi, S. Zibaee, R. Jakes, L.C. Serpell, B. Davletov, R.A. Crowther, and M. Goedert Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein FEBS Lett. 576 2004 363 368
10. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, and P.T. Lansbury Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc. Natl. Acad. Sci. USA 97 2000 571 576
11. S. Krishan, E.Y. Chi, S.J. Wood, B.S. Kendrick, C. Li, W. Garzon-Rodriguez, J. Wypych, T.W. Randolph, L.O. Narhi, A.L. Biere, M. Citron, and J.F. Carpenter Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis Biochemistry 42 2003 829 837
12. J.M. Souza, B.I. Giasson, Q. Chen, V.M.Y. Lee, and H. Ischiropoulos Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies J. Biol. Chem. 274 2000 18344 18349
13. R. Jakes, M.G. Spillantini, and M. Goedert Identification of two distinct synucleins from human brain FEBS Lett. 345 1994 27 32
14. D. Suckau, A. Resemann, M. Schuerenberg, P. Hufnagel, J. Franzen, and A. Holle A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics Anal. Bioanal. Chem. 376 2003 952 965
15. S. Taniguchi, N. Suzuki, M. Masuda, S. Hisanaga, T. Iwatsubo, M. Goedert, and M. Hasegawa Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins J. Biol. Chem. 280 2005 7614 7623
16. J.B. Rice, J.J. Seyer, and J.N. Reeve Identification of sites of cysteine misincorporation during in vivo synthesis of bacteriophage T7 0.3 protein Biochim. Biophys. Acta 867 1986 57 66
17. W. Zhou, and C.R. Freed Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity J. Biol. Chem. 279 2004 10128 10135